Lloyd Mitchell Segal

Lloyd Mitchell Segal is an accomplished executive in the biotechnology and healthcare sectors, currently serving as President and Chief Executive Officer of Repare Therapeutics, a clinical-stage precision oncology company, since June 2016. Segal holds board positions with Aktis Oncology and Pembroke Private Wealth Management, and has previously worked as a Board Member for LMC Diabetes & Endocrinology and Valeant Pharmaceuticals. Segal's extensive experience includes serving as Entrepreneur in Residence at Versant Ventures, where the focus was on developing new healthcare companies, and as Chairman of the Board at MedReleaf, which achieved substantial growth before its acquisition by Aurora Cannabis. Educated at Harvard Business School with an MBA and Brandeis University with a BA in Politics, Segal has founded and led various organizations, contributing significantly to healthcare investment and management.